Luyan Pharma Co.,Ltd. (SHE:002788)
China · Delayed Price · Currency is CNY 10.78
+0.34 (3.26%)
Sep 16, 2026, 3:04 PM CST
Luyan Pharma Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 21,375 | 21,189 | 20,398 | 19,785 | 19,406 | 17,508 |
Other Revenue | 54.08 | 57.35 | 72.73 | 60.56 | 56.58 | 37.16 |
| 21,429 | 21,247 | 20,471 | 19,846 | 19,463 | 17,545 | |
Revenue Growth | 4.20% | 3.79% | 3.15% | 1.97% | 10.93% | 12.94% |
Cost of Revenue | 19,946 | 19,749 | 18,948 | 18,339 | 17,950 | 16,179 |
Gross Profit | 1,483 | 1,497 | 1,523 | 1,506 | 1,512 | 1,366 |
Selling, General & Admin | 867.71 | 849.34 | 789.17 | 750.99 | 731.55 | 701.2 |
Research & Development | 7.45 | 6.52 | 5.85 | 5.53 | 4.15 | 2.97 |
Other Operating Expenses | 56.12 | 53.47 | 46.9 | 42.15 | 41.59 | 37.85 |
Operating Expenses | 932.62 | 920.25 | 838.39 | 811.62 | 809.68 | 765.63 |
Operating Income | 550.2 | 577.17 | 684.26 | 694.86 | 702.35 | 600.39 |
Interest Expense | -164.08 | -178.36 | -206.68 | -222.85 | -219.1 | -190.28 |
Interest & Investment Income | 2.05 | 2.66 | 3.84 | 5.14 | 3.86 | 5.18 |
Currency Exchange Gain (Loss) | -0.19 | 0.77 | -0.95 | -0.03 | 0.1 | 0.01 |
Other Non Operating Income (Expenses) | -14.38 | -12.52 | -12.08 | -6.95 | -22.91 | -13.14 |
EBT Excluding Unusual Items | 373.6 | 389.72 | 468.38 | 470.16 | 464.3 | 402.15 |
Impairment of Goodwill | - | - | - | - | - | -1.89 |
Gain (Loss) on Sale of Investments | -16.55 | -14.33 | -18.73 | -12.16 | -6.92 | -2.14 |
Gain (Loss) on Sale of Assets | -0.31 | 0.26 | 0.17 | 0.28 | 0.13 | -0.53 |
Asset Writedown | -0.36 | -0.44 | -0.09 | -0.13 | -0.03 | -1.7 |
Other Unusual Items | 5.51 | 1.01 | 3.53 | 11.27 | 8.54 | 19.33 |
Pretax Income | 361.88 | 376.23 | 453.27 | 469.42 | 466.01 | 415.22 |
Income Tax Expense | 96.52 | 97.25 | 105.58 | 104.93 | 115.04 | 110.6 |
Earnings From Continuing Operations | 265.36 | 278.98 | 347.7 | 364.49 | 350.97 | 304.61 |
Minority Interest in Earnings | 4 | 1.9 | -2.05 | -0.96 | -5.82 | 1.26 |
Net Income | 269.36 | 280.88 | 345.64 | 363.53 | 345.16 | 305.87 |
Net Income to Common | 269.36 | 280.88 | 345.64 | 363.53 | 345.16 | 305.87 |
Net Income Growth | -13.05% | -18.74% | -4.92% | 5.32% | 12.84% | 14.72% |
Shares Outstanding (Basic) | 390 | 390 | 388 | 387 | 388 | 387 |
Shares Outstanding (Diluted) | 390 | 390 | 388 | 387 | 388 | 387 |
Shares Change | 0.76% | 0.45% | 0.42% | -0.28% | 0.17% | 7.46% |
EPS (Basic) | 0.69 | 0.72 | 0.89 | 0.94 | 0.89 | 0.79 |
EPS (Diluted) | 0.69 | 0.72 | 0.89 | 0.94 | 0.89 | 0.79 |
EPS Growth | -13.71% | -19.10% | -5.32% | 5.62% | 12.66% | 6.76% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 172.69 | 454.66 | 216.36 | 779.91 | -95.4 | -615.51 |
Free Cash Flow Per Share | 0.44 | 1.17 | 0.56 | 2.02 | -0.25 | -1.59 |
Dividend Per Share | 0.350 | 0.350 | 0.350 | 0.300 | 0.300 | 0.300 |
Dividend Growth | 0% | 0% | 16.67% | 0% | 0% | 50.00% |
Gross Margin | 6.92% | 7.05% | 7.44% | 7.59% | 7.77% | 7.79% |
Operating Margin | 2.57% | 2.72% | 3.34% | 3.50% | 3.61% | 3.42% |
Profit Margin | 1.26% | 1.32% | 1.69% | 1.83% | 1.77% | 1.74% |
Free Cash Flow Margin | 0.81% | 2.14% | 1.06% | 3.93% | -0.49% | -3.51% |
EBITDA | 629.01 | 650.21 | 752.83 | 753.71 | 757.8 | 654.87 |
EBITDA Margin | 2.94% | 3.06% | 3.68% | 3.80% | 3.89% | 3.73% |
D&A For EBITDA | 78.81 | 73.04 | 68.57 | 58.85 | 55.45 | 54.48 |
EBIT | 550.2 | 577.17 | 684.26 | 694.86 | 702.35 | 600.39 |
EBIT Margin | 2.57% | 2.72% | 3.34% | 3.50% | 3.61% | 3.42% |
Effective Tax Rate | 26.67% | 25.85% | 23.29% | 22.35% | 24.69% | 26.64% |
Revenue as Reported | 21,429 | 21,247 | 20,471 | 19,846 | 19,463 | 17,545 |
Advertising Expenses | - | 3.99 | 5.53 | 1.27 | 1.94 | 1.7 |